Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001493083 | SCV001697705 | likely benign | Mucopolysaccharidosis type 1 | 2022-09-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003169289 | SCV003859504 | likely benign | Inborn genetic diseases | 2022-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001493083 | SCV002075304 | likely benign | Mucopolysaccharidosis type 1 | 2020-10-19 | no assertion criteria provided | clinical testing |